Facing Neonatal Stenotrophomonas Maltophilia Infection: TrimethoprimSulfamethoxazole or Levofloxacin?
Abstract
No Abstract
1. Lewis S, Zaas A.In:Sexton D, Bloom A, editors. UpToDate [Internet]. Waltham (MA): UpToDate Inc; 2019 [cited 2019 Jul 14]. Available from: https:// https://www.uptodate.com/contents/stenotrophomonas-maltophilia/ print?source=related_link.
2. Ryan KL, Dersch-Mills D, Clark D. Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Pneumonia in a Neonate. Can J Hosp Pharm 2013;66(6):384-7
3. Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol 2015;6:893.
4. Andersen DH, Blanc WA, Crozier DN, et al. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956;18(4):614-25.
5. Sinclair JC. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens by William A. Silverman et al, Pediatric 1956; 18: 614-624. Pediatrics 1988; 102:225.
6. Thyagarajan B, Deshpande SS. Cotrimoxazole and neonatal kernicterus: a review. Drug Chem Toxicol 2014, 37 (2):121-9.
7. Guzoglu N, Demirkol FN, Aliefendioglu D. Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns. J Infect Dev Ctries 2015;9(5):533-5.
8. Adefurin A, Sammons H, Jacqz-Aigrain E, et al. Ciprofloxacin safety in pediatrics: a systematic review. Arch Dis Child 2011; 96:874-880.
9. Faghihi T, Yavari Tekmehdash L, et al. Ciprofloxacin use in hospitalized children: approved or off-label? J Res Pharm Pract 2017;6:193-8.
10. Bradley JS, Kauffman RE, Balis DA, et al. Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. Pediatrics 2014;134, e146.
11. Ko JH, Kang CI, Cornejo-Juárez P, et al. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect 2019;25(5):546-54.
2. Ryan KL, Dersch-Mills D, Clark D. Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Pneumonia in a Neonate. Can J Hosp Pharm 2013;66(6):384-7
3. Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol 2015;6:893.
4. Andersen DH, Blanc WA, Crozier DN, et al. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956;18(4):614-25.
5. Sinclair JC. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens by William A. Silverman et al, Pediatric 1956; 18: 614-624. Pediatrics 1988; 102:225.
6. Thyagarajan B, Deshpande SS. Cotrimoxazole and neonatal kernicterus: a review. Drug Chem Toxicol 2014, 37 (2):121-9.
7. Guzoglu N, Demirkol FN, Aliefendioglu D. Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns. J Infect Dev Ctries 2015;9(5):533-5.
8. Adefurin A, Sammons H, Jacqz-Aigrain E, et al. Ciprofloxacin safety in pediatrics: a systematic review. Arch Dis Child 2011; 96:874-880.
9. Faghihi T, Yavari Tekmehdash L, et al. Ciprofloxacin use in hospitalized children: approved or off-label? J Res Pharm Pract 2017;6:193-8.
10. Bradley JS, Kauffman RE, Balis DA, et al. Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. Pediatrics 2014;134, e146.
11. Ko JH, Kang CI, Cornejo-Juárez P, et al. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect 2019;25(5):546-54.
| Files | ||
| Issue | Vol 7, No 3 (Summer2019) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/jpc.v7i3.2349 | |
| Keywords | ||
| Keywords Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Faghihi T. Facing Neonatal Stenotrophomonas Maltophilia Infection: TrimethoprimSulfamethoxazole or Levofloxacin?. J Pharm Care. 2019;7(3):39-40.
